GR3019618T3 - Oxetanones - Google Patents

Oxetanones

Info

Publication number
GR3019618T3
GR3019618T3 GR960401013T GR960401013T GR3019618T3 GR 3019618 T3 GR3019618 T3 GR 3019618T3 GR 960401013 T GR960401013 T GR 960401013T GR 960401013 T GR960401013 T GR 960401013T GR 3019618 T3 GR3019618 T3 GR 3019618T3
Authority
GR
Greece
Prior art keywords
oxetanones
novel
formula
image
disclosed
Prior art date
Application number
GR960401013T
Other languages
English (en)
Inventor
Romano Dr Derungs
Hans Peter Dr Maerki
Henri Dr Stalder
Andre Dr Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of GR3019618T3 publication Critical patent/GR3019618T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
GR960401013T 1990-02-26 1996-04-09 Oxetanones GR3019618T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH400590 1990-12-17

Publications (1)

Publication Number Publication Date
GR3019618T3 true GR3019618T3 (en) 1996-07-31

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401013T GR3019618T3 (en) 1990-02-26 1996-04-09 Oxetanones

Country Status (18)

Country Link
EP (1) EP0444482B1 (el)
JP (1) JP2753403B2 (el)
KR (1) KR0183036B1 (el)
AT (1) ATE133167T1 (el)
AU (1) AU645291B2 (el)
CA (1) CA2035967C (el)
DE (1) DE59107262D1 (el)
DK (1) DK0444482T3 (el)
ES (1) ES2082869T3 (el)
FI (1) FI115054B (el)
GR (1) GR3019618T3 (el)
HU (1) HU218272B (el)
IE (1) IE72196B1 (el)
IL (1) IL97148A (el)
MC (1) MC2226A1 (el)
NO (1) NO177055C (el)
NZ (1) NZ237170A (el)
PT (1) PT96887B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
NL1004559C2 (nl) * 1996-11-18 1998-05-19 Unilife Boter.
WO2001032616A2 (en) * 1999-10-29 2001-05-10 John Jason Gentry Mullins Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CA2704462A1 (en) 2007-10-31 2009-05-07 Burnham Institute For Medical Research Beta-lactone compounds
CN111343999B (zh) * 2017-07-12 2022-03-01 梅约医学教育与研究基金会 减少脂毒性损伤的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) * 1984-08-09 1994-08-31 三菱電機株式会社 遅延線

Also Published As

Publication number Publication date
HU218272B (en) 2000-07-28
MC2226A1 (fr) 1993-02-02
AU7122891A (en) 1991-08-29
IE72196B1 (en) 1997-03-26
ES2082869T3 (es) 1996-04-01
FI910925A (fi) 1991-08-27
AU645291B2 (en) 1994-01-13
JPH0770099A (ja) 1995-03-14
DK0444482T3 (da) 1996-05-06
KR0183036B1 (ko) 1999-05-01
EP0444482A3 (en) 1991-12-04
PT96887B (pt) 1998-09-30
DE59107262D1 (de) 1996-02-29
CA2035967C (en) 2001-10-16
ATE133167T1 (de) 1996-02-15
JP2753403B2 (ja) 1998-05-20
NO177055C (no) 1995-07-12
NO910729L (no) 1991-08-27
FI115054B (fi) 2005-02-28
IL97148A (en) 1996-11-14
EP0444482B1 (de) 1996-01-17
EP0444482A2 (de) 1991-09-04
NO910729D0 (no) 1991-02-25
HUT56557A (en) 1991-09-30
IE910631A1 (en) 1991-08-28
FI910925A0 (fi) 1991-02-26
IL97148A0 (en) 1992-05-25
KR910021391A (ko) 1991-12-20
NZ237170A (en) 1993-12-23
NO177055B (no) 1995-04-03
CA2035967A1 (en) 1991-08-27
PT96887A (pt) 1991-10-31

Similar Documents

Publication Publication Date Title
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
HU9700022D0 (en) Dihydrobenzofuranes
AU2144688A (en) Curable organosiloxane compositions
AU3117495A (en) Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
EP0444482A3 (en) Oxetanones
AP9400632A0 (en) Ether derivatives.
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
AU1630288A (en) Substituted compounds, processes for their preparation and uses thereof
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
EP0614908A3 (en) Method of preparation of 3-beta-aminocholanic acid derivatives.
EP0529444A3 (en) 2-arylpropenic acids and their utilisation in the preparation of 5-ketoprofen
PL297491A1 (en) Aryl hydroxyimidazolinylpropionamides
RU1804487C (ru) Колошник
IL107142A0 (en) Tetrahydroindazolone pharmaceutical compositions
PL292615A2 (en) Shaft furance
IE901508L (en) Stabilization of carboxyl esterase
ES8605530A1 (es) Procedimiento para la obtencion de triazolil-tionofosfatos